Robotics in Pharmaceutical Manufacturing

1. Objective of the Survey

Objective Description
Adoption understanding Understand how robotics is currently being adopted in pharmaceutical manufacturing
Use cases & challenges Identify key use cases, benefits, and challenges
US vs EU comparison Compare adoption trends between the US and EU
Future & workforce Assess future investment intentions and workforce impact

2. Survey Demographics (Summary)

Respondents
Total respondents 75
Geography
United States 50 (67%)
European Union 25 (33%)
Roles Represented
Manufacturing & Operations Managers
Process Engineers
Quality & Compliance Leaders
Automation / Digital Transformation Heads
Facility Types
Small-molecule manufacturing
Biologics & vaccines
CDMOs

3. Key Outcomes (Executive Summary)

# Outcome
1 Robotics adoption is no longer experimental; it is becoming operationally essential
2 Sterile manufacturing, packaging, and quality inspection are the fastest-growing use cases
3 US facilities show faster scaling, while EU facilities emphasize compliance-driven automation
4 Workforce impact is role transformation, not job elimination
5 ROI is primarily driven by quality, compliance, and uptime, not just labor reduction

4. Survey Findings

Q1. Are you currently using robotics in your manufacturing operations?

Response Overall US EU
Yes – extensively36%40%28%
Yes – limited/pilot44%42%48%
No – but planning16%14%20%
No plans4%4%4%

Q2. Which manufacturing areas use robotics most today?

Area % of Respondents
Packaging & labeling68%
Sterile fill-finish61%
Material handling56%
Visual inspection / QA49%
Compounding & dispensing32%
Regional Trends
US trendHigher use in high-throughput packaging
EU trendStronger focus on sterility and contamination control

Q3. What are the primary drivers for adopting robotics?

Driver % Selecting
Improved product quality72%
Regulatory compliance65%
Labor shortages58%
Reduced human error55%
Cost reduction41%

Q4. How has robotics impacted manufacturing performance?

Impact Area Positive Impact Reported
Batch consistency74%
Deviation reduction69%
Throughput increase63%
Downtime reduction52%
Scrap/reject reduction48%

Q5. What challenges limit wider robotics adoption?

Challenge % of Respondents
High upfront investment67%
Integration with legacy systems59%
Validation & qualification effort54%
Skills gap46%
Change management resistance33%

EU respondents cited validation complexity more frequently than US respondents.

Q6. How has robotics affected the workforce?

Impact %
Roles shifted to higher-skill tasks62%
Increased need for automation skills58%
No net job loss observed55%
Reduction in manual operators28%

Q7. What level of ROI has robotics delivered?

ROI Perception %
Strong ROI achieved34%
Moderate ROI46%
ROI still being evaluated16%
Underperforming4%
Primary ROI Contributors
Reduced deviations
Faster batch release
Improved audit outcomes

Q8. Are you planning to increase robotics investment in the next 3 years?

Response %
Yes – significantly42%
Yes – moderately39%
No change15%
Reduce investment4%
Outlook by Region
US outlookAggressive scaling
EU outlookTargeted, compliance-focused expansion

Q9. Which future robotics capabilities are most important?

Capability %
AI-enabled inspection66%
Collaborative robots (cobots)61%
Autonomous material transport54%
Digital twin integration47%
Self-validating systems39%

5. Overall Conclusion

Theme Summary
Quality & compliance Raising quality and compliance standards
Process stability Reducing process variability
Operations Enabling scalable, sterile, and resilient operations
Workforce Driving a skills upgrade, not workforce displacement
Regional nuance US manufacturers move faster in scale and experimentation; EU manufacturers embed robotics deeply into regulatory and sterility frameworks
Thought Leadership

Trusted by Industry Leaders

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.

SPER-Astellas Pharma
SPER-Microsoft
SPER-EY
SPER-McKinsey
SPER-Bain
SPER-Max-Healthcare
SPER-DHL
SPER-IQVIA
SPER-Mitsubishi Logistics
SPER-PACCOR
SPER-Macmillan Education
SPER-Kankar IMRB
SPER-ITA
SPER-PWC
SPER-SAPTCA
SPER-Straumann
SPER-Danaher
SPER-AandM
SPER-MENARINI Silicon Biosystems
SPER-IPSOS
SPER-Heineken
HIPPA Compliant
GDPR Certified
ISO 27001
Peer Reviewed
Get Started Today

Your Competitive Advantage in
Pharmaceutical & Medical Technology
Markets

Join industry leaders leveraging AI-powered intelligence to make confident, data-driven decisions that accelerate breakthrough treatments and technologies to market.

No Credit Card Required
15-Minute Demo
Expert Guidance